Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 3
2012 3
2013 4
2014 6
2015 4
2016 7
2017 7
2018 7
2019 16
2020 30
2021 24
2022 13
2023 16
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Secukinumab in plaque psoriasis--results of two phase 3 trials.
Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C; ERASURE Study Group; FIXTURE Study Group. Langley RG, et al. N Engl J Med. 2014 Jul 24;371(4):326-38. doi: 10.1056/NEJMoa1314258. Epub 2014 Jul 9. N Engl J Med. 2014. PMID: 25007392 Free article. Clinical Trial.
Potential Indications of Dupilumab in Th-2 Inflammatory Disease.
Ilaria P, Nevena S, Ersilia T, Nicoletta B, Trovato F, Di Fraia M, Agniezska D, Concetta P. Ilaria P, et al. Among authors: concetta p. Rev Recent Clin Trials. 2023 Dec 20. doi: 10.2174/0115748871263396231121060901. Online ahead of print. Rev Recent Clin Trials. 2023. PMID: 38141197
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years.
Patruno C, Fabbrocini G, Lauletta G, Boccaletti V, Colonna C, Cavalli R, Neri I, Ortoncelli M, Schena D, Stingeni L, Hansel K, Piccolo V, Di Brizzi V, Potenza C, Tolino E, Bianchi L, Manti S, De Pasquale R, Di Lernia V, Caminiti L, Galli E, Coppo P, Chiricozzi A, De Simone C, Guerriero C, Amoruso FG, Provenzano E, Leonardi S, Licari A, Marseglia GL, Palermo A, Di Pillo S, Russo D, Moschese V, Patella V, Peduto T, Ferreli C, Zangari P, Veronese F, Berti SF, Gruber M, Pezzolo E, Termine S, Satta R, Dragoni F, Esposito M, Fargnoli MC, Chiodini P, Vallone Y, di Vico F, Picone V, Napolitano M. Patruno C, et al. Among authors: potenza c. J Dermatolog Treat. 2023 Dec;34(1):2246602. doi: 10.1080/09546634.2023.2246602. J Dermatolog Treat. 2023. PMID: 37580895 Free article.
BRAF Inhibitors: Molecular Targeting and Immunomodulatory Actions.
Proietti I, Skroza N, Michelini S, Mambrin A, Balduzzi V, Bernardini N, Marchesiello A, Tolino E, Volpe S, Maddalena P, Di Fraia M, Mangino G, Romeo G, Potenza C. Proietti I, et al. Among authors: potenza c. Cancers (Basel). 2020 Jul 7;12(7):1823. doi: 10.3390/cancers12071823. Cancers (Basel). 2020. PMID: 32645969 Free PMC article. Review.
The Skin in Celiac Disease Patients: The Other Side of the Coin.
Abenavoli L, Dastoli S, Bennardo L, Boccuto L, Passante M, Silvestri M, Proietti I, Potenza C, Luzza F, Nisticò SP. Abenavoli L, et al. Among authors: potenza c. Medicina (Kaunas). 2019 Sep 9;55(9):578. doi: 10.3390/medicina55090578. Medicina (Kaunas). 2019. PMID: 31505858 Free PMC article. Review.
Aesthetic Treatments in Cancer Patients.
Proietti I, Skroza N, Mambrin A, Marraffa F, Tolino E, Bernardini N, Marchesiello A, Rossi G, Volpe S, Potenza C. Proietti I, et al. Among authors: potenza c. Clin Cosmet Investig Dermatol. 2021 Dec 4;14:1831-1837. doi: 10.2147/CCID.S342734. eCollection 2021. Clin Cosmet Investig Dermatol. 2021. PMID: 34898993 Free PMC article.
Women and acne: any difference from males? A review of the literature.
Skroza N, Tolino E, Proietti I, Bernardini N, La Viola G, Nicolucci F, Pampena R, Zuber S, Balduzzi V, Soccodato V, Mancini MT, Potenza C. Skroza N, et al. Among authors: potenza c. G Ital Dermatol Venereol. 2016 Feb;151(1):87-92. Epub 2014 Sep 18. G Ital Dermatol Venereol. 2016. PMID: 25236316 Review.
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
van Straalen KR, Tzellos T, Alavi A, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Guillem P, Gulliver W, Jemec GBE, Katoulis A, Koenig A, Lazaridou E, Lowes MA, Marzano AV, Matusiak L, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Prens EP, Romaní J, Saunte DM, Sayed C, Skroza N, Stergianou D, Szepietowski JC, Trigoni A, Vilarrasa E, Kyrgidis A, Zouboulis CC, van der Zee HH. van Straalen KR, et al. Among authors: potenza c. Dermatology. 2023;239(3):362-367. doi: 10.1159/000528968. Epub 2023 Jan 30. Dermatology. 2023. PMID: 36630943 Free article.
Postacne scarring: which factors are involved?
Tolino E, Skroza N, Proietti I, Bernardini N, Balduzzi V, Anzalone A, LA Torre G, Marchesiello A, Mambrin A, Potenza C. Tolino E, et al. Among authors: potenza c. G Ital Dermatol Venereol. 2020 Dec;155(6):793-794. doi: 10.23736/S0392-0488.19.06154-6. Epub 2019 Jul 12. G Ital Dermatol Venereol. 2020. PMID: 31302974 No abstract available.
125 results